DaVita reports Q2 2023 revenue of $3.0B; diluted EPS $1.91, adjusted EPS $2.08

DAVITA INC.

2023-Q2 EPS reported $3.17 revenue$5,873,068,000

Consolidated revenue $3.0B; operating income $405M; adjusted operating income $432M.
Diluted GAAP EPS $1.91; adjusted diluted EPS $2.08; free cash flow $260M.
Refinanced existing term loan and revolver with new $1.25B Term Loan A-1 and $1.5B revolver.
Six-month net income $294M vs $387M in prior year, a 24% decline.
CEO highlights strong clinical innovation and operational improvements; reaffirms full-year outlook.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DAVITA INC. reported the quarter ended June 30, 2023 results: revenue $3.0 billion, net income $179 million, EPS $1.91.

Period: the quarter ended June 30, 2023
Revenue: $3.0 billion
Net income: $179 million
EPS: $1.91
Result: reported results

Exact text from the filing

to deliver strong clinical outcomes and financial results for the year." Financial and operating highlights for the quarter ended June 30, 2023: • Consolidated revenues were $3.0 billion. • Operating income was $405 million and adjusted operating income was $432 million. • Diluted earnings per share was $1.91 and adjusted diluted earnings per share was $2.08. •

View on SEC.gov

Browse all earnings releases →

DAVITA INC. filing history →

Source: SEC EDGAR

accession 0000927066-23-000175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.